ライフサイエンスコーパス: artery

1 ow-mediated dilatation (FMD) of the brachial artery.

2 ced percutaneously (day 0) in the circumflex artery.

3 s even after flow is restored in an upstream artery.

4 , and can always be traced back to the renal artery.

5 ithout surgical intervention of the skull or artery.

6 perties in phantom and human cadaver carotid arteries.

7 with vascular remodeling of the stem villus arteries.

8 tical plaque pathophysiology in the coronary arteries.

9 e pressor reflex in rats with patent femoral arteries.

10 SN5 is up-regulated in human atherosclerotic arteries.

11 D1/5/8 were activated in developing coronary arteries.

12 early arteriogenesis but was down in mature arteries.

13 migration against blood flow into developing arteries.

14 ylation of VE-cadherin were increased in old arteries.

15 ndothelial dilatation in old, but not young, arteries.

16 ardial ischemia with no obstructive coronary arteries.

17 r the endothelial dilator dysfunction in old arteries.

18 ascular fat compartment located around renal arteries.

19 erin were increased in old compared to young arteries.

20 uctive disease of the precapillary pulmonary arteries.

21 ic oxide (NO) in mouse mesenteric resistance arteries.

22 alled medin within the medial layer of large arteries.

23 (DEB-TACE), which was given via the hepatic artery 2-5 weeks after randomisation and according to ra

24 rformed predominantly with the use of radial-artery access.

25 ndings included hypertrophy of the bronchial arteries along the mediastinal course, diffuse thickenin

26 30-fold higher than AT1 Ra in whole cerebral arteries and approximately 45-fold higher in isolated ce

27 olecular pathways for the specific growth of arteries and lymphatic vessels have been identified, but

28 atients with chest pain with normal coronary arteries and no clinical events during follow-up (minima

29 oninvasive testing will have normal coronary arteries and no long-term clinical events.

30 stologically, lungs showed ectatic pulmonary arteries and pulmonary veins.

31 stent implantation into aorto-iliac/visceral arteries and the vena cava (temporal resolution, five im

32 a smaller percentage of FMD of the brachial artery and higher salivary levels of MMP-2/TIMP-2 comple

33 derwent catheterization of the right femoral artery and left femoral vein.

34 the territory subtended by a single coronary artery and recovers within days or weeks.

35 ationship between PI values of the popliteal artery and the number of thrombosed calf veins was inves

36 ery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were recruited.

37 r structures, wall thickening of some portal arteries, and periductal fibrosis in Fut2(-/-)(high) mic

38 left circumflex artery (LCx), right coronary artery, and all three coronary arteries combined were co

39 , small bowel behind the superior mesenteric artery, and right-sided anastomosis.

40 An incidental finding of a bronchial artery aneurysm necessitates prompt treatment.

41 Hepatic artery aneurysms represent a significant risk for hemorr

42 Coronary artery anomalies may cause life-threatening cardiac comp

43 Considering the dilation of the pulmonary arteries as a paramount sign of PAH, we hypothesized tha

44 significant stenosis in at least 1 coronary artery as indicated by a fractional flow reserve of 0.80

45 the endovascular distances from both femoral arteries at the level of the upper border of the symphys

46 Large artery atherosclerotic stroke (LAS) shows substantial he

47 ight coronary artery (RCA) and left coronary artery balloon occlusion at baseline before and at follo

48 tch operation) or 2-stage repairs (pulmonary artery band followed by arterial switch operation).

49 e survival after bilateral internal thoracic artery (BITA) over single left internal thoracic artery

50 en saturation (pulse oximetry), and brachial artery blood flow and shear rate (ultrasound) were recor

51 endothelial recovery in wire-injured carotid arteries, but this effect was also abrogated by lack of

52 ad improved long-term outcomes with coronary artery bypass graft (CABG) surgery compared with percuta

53 cute coronary syndromes or previous coronary artery bypass graft surgery in periods before (2010 thro

54 A) can improve clinical outcomes in coronary artery bypass graft surgery remains unclear.

55 no acute coronary syndrome/no prior coronary artery bypass graft surgery that were rated as inappropr

56 l infarction, coronary angioplasty, coronary artery bypass graft surgery, stroke).

57 ervention, or previous multi-vessel coronary artery bypass graft surgery.

58 ADBRs included non-coronary artery bypass graft-related Thrombolysis In Myocardial I

59 189229 patients at 1876 hospitals), coronary artery bypass grafting (CABG) (218940 patients at 1056 h

60 whether revascularization by either coronary artery bypass grafting (CABG) or percutaneous coronary i

61 Of 10 633 adults who underwent coronary artery bypass grafting and valve surgery between January

62 trum of patients who are undergoing coronary artery bypass grafting in routine practice.

63 tive analysis of 47 984 consecutive coronary artery bypass grafting surgeries performed from 1992 to

64 clinical trial, patients undergoing coronary artery bypass grafting with an internal mammary artery a

65 ection fraction who were undergoing coronary artery bypass grafting with cardiopulmonary bypass, levo

66 nalysis of patients undergoing only coronary artery bypass grafting, and results were similar.

67 e considered more frequently during coronary artery bypass grafting.

68 coronary intervention (28%), urgent coronary artery bypass surgery (27.5%), maternal mortality (4%),

69 Coronary artery bypass surgery was performed in 44 cases because

70 Coronary artery calcification (CAC) is highly prevalent in dialys

71 Coronary artery calcification (CAC) may impair diagnostic assessm

72 etween the polygenic risk score and coronary artery calcification (CARDIA) and carotid artery plaque

73 At baseline, 70 men (50.7%) had a coronary artery calcification score higher than 300 Agatston unit

74 oral, and abdominal aortic plaques; coronary artery calcification; serum biomarkers; and lifestyle.

75 It is not known whether coronary artery calcium (CAC) assessment at baseline in individua

76 o examine the predictive ability of coronary artery calcium (CAC) score vs age for incident ASCVD and

77 e relationships among adult height, coronary artery calcium (CAC) score, incident atherosclerotic car

78 versies regarding the usefulness of coronary artery calcium score (CACS) for predicting coronary arte

79 Coronary artery calcium score was more likely than age to provide

80 med soon after recanalization of the culprit artery, cardiac magnetic resonance performed during inde

81 ucing a peripheral intravenous and pulmonary artery catheter, respectively, after zeroing at the phle

82 Common carotid artery (CCA) balloon angioplasty injury was performed in

83 etinoblastoma vitreous seeds with ophthalmic artery chemosurgery (OAC) alone versus OAC with intravit

84 ight coronary artery, and all three coronary arteries combined were compared with microsphere perfusi

85 6 weeks after distal right internal mammary artery device closure.

86 ining primary cardiac diagnosis was coronary artery disease (32.3%-19.0%; P<0.001).

87 The prevalence of coronary artery disease (CAD) among patients with refractory out-

88 h QTc prolongation in patients with coronary artery disease (CAD) and investigate the effects of huma

89 patients with 3-vessel or left main coronary artery disease (CAD) had improved long-term outcomes wit

90 ting for a diagnosis of significant coronary artery disease (CAD) is ambiguous, but nuclear myocardia

91 ANGPTL3 deficiency reduces risk of coronary artery disease (CAD) is unknown.

92 e models to predict the presence of coronary artery disease (CAD) may help reduce the societal burden

93 iated with cardiovascular events in coronary artery disease (CAD) patients and reducing the hs-CRP le

94 Coronary artery disease (CAD) severity was quantified in each sub

95 METHODS AND Obstructive coronary artery disease (CAD) was defined as >/=50% stenosis on a

96 pretest probability for obstructive coronary artery disease (CAD) were randomly assigned to functiona

97 higher calcium had a higher risk of coronary artery disease (CAD), myocardial infarction (MI) and the

98 style counseling in patients with peripheral artery disease (PAD) in the United States.

99 Peripheral artery disease (PAD) is associated with increased cardio

100 ethods investigation (compared with coronary artery disease and hypertension).

101 increasingly popular in the area of coronary artery disease and its risk factors, many of the more ad

102 medical treatment in patients with coronary artery disease and left ventricular ejection fraction </

103 reatment (two in the control group [coronary artery disease and multiorgan failure] and three in the

104 t of a recent GWAS meta-analysis of coronary artery disease and provide a list of targeted eGenes for

105 e been used for 30 years to prevent coronary artery disease and stroke.

106 ependent metabolite associated with coronary artery disease and stroke.

107 emic if peripheral neuropathy and peripheral artery disease are both present.

108 s (DCB) for the treatment of femoropopliteal artery disease are encouraging.

109 Future peripheral artery disease cell therapy investigational trial design

110 In a coronary artery disease cohort separate from volunteers of this s

111 had a lower pretest probability of coronary artery disease compared with men.

112 ty-five patients with symptomatic peripheral artery disease due to de novo superficial femoral artery

113 onary angiography revealed positive coronary artery disease findings in 16 patients; LAD was affected

114 lication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium's

115 to 61079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis

116 on previous revascularization for peripheral artery disease had higher rates of myocardial infarction

117 Eligible patients with coronary artery disease had to have had a myocardial infarction i

118 Patients with peripheral artery disease have an increased risk of cardiovascular

119 ies have assessed the prevalence of coronary artery disease in masters athletes with a low atheroscle

120 g occluded and significantly stenotic tibial artery disease in these patients compared with ankle pul

121 ss of ACS patients with obstructive coronary artery disease is associated with a high reclassificatio

122 Peripheral artery disease is considered to be a manifestation of sy

123 trated among patients with stable peripheral artery disease is elevated after revascularization and r

124 have the lowest reported levels of coronary artery disease of any population recorded to date.

125 een 2005 and 2014 because of stable coronary artery disease or acute coronary syndrome were included

126 itivity with known/suspected stable coronary artery disease or presenting with an acute coronary synd

127 adverse cardiovascular outcomes in coronary artery disease patients.

128 f elevated WBC across a spectrum of coronary artery disease presentations are warranted.

129 years), mostly with an intermediate coronary artery disease probability, between cardiac CT and funct

130 n) at 1 year in 2,008 patients with coronary artery disease randomized to BVS versus cobalt-chromium

131 gic shock in swine with preexisting coronary artery disease reduced renal dysfunction and cardiac inj

132 association between rs11556924 and coronary artery disease risk by characterizing its effects on the

133 FR and ACR significantly improved peripheral artery disease risk discrimination beyond traditional pr

134 Conventional coronary artery disease risk factors might potentially explain at

135 ion of the Bolivian Amazon with few coronary artery disease risk factors, have the lowest reported le

136 ial lifestyle and low prevalence of coronary artery disease risk factors, we examined the Tsimane, a

137 ge, sex, and low Framingham 10-year coronary artery disease risk scores with an echocardiogram, exerc

138 otal number of loci associated with coronary artery disease to 95 at the time of analysis.

139 ith best MT in patients with stable coronary artery disease to assess clinical outcomes and cost-effe

140 ts (n = 4,057) without a history of coronary artery disease underwent CZT SPECT MPI.

141 of statin intolerance, diabetes, or coronary artery disease were not eligible.

142 n statins) with no prior history of coronary artery disease who had a screening CACS >/=300 Agatston

143 om those of trials with multivessel coronary artery disease without left main LMCA stenosis.

144 to Functional Testing for Suspected Coronary Artery Disease) prospectively randomized 350 patients wi

145 2 1 method required the presence of coronary artery disease, a common interpretation of the 2007 univ

146 I, height, systolic blood pressure, coronary artery disease, and type 2 diabetes using data from six

147 ow-density lipoprotein cholesterol, coronary artery disease, C-reactive protein, HbA1c, height, obesi

148 ng initial evaluation for suspected coronary artery disease, coronary CTA was associated with greater

149 in the past 20 years, multi-vessel coronary artery disease, history of stable or unstable angina, pr

150 r five vascular diseases, including coronary artery disease, migraine headache, cervical artery disse

151 tpatients presenting with suspected coronary artery disease, most patients experiencing clinical even

152 2007); and 1 method did not require coronary artery disease, the 2012 universal definition (T2MI2012)

153 protein] gene increases the risk of coronary artery disease, the leading cause of death worldwide.

154 ferred increased risk of incident peripheral artery disease, with a strong association between albumi

155 This paper reports on patients with coronary artery disease.

156 ac masses, pericardial disease, and coronary artery disease.

157 each other in patients with stable coronary artery disease.

158 assessing physiological severity of coronary artery disease.

159 compared with patients with stable coronary artery disease.

160 n the management of patients with peripheral artery disease.

161 a risk factor for lower-extremity peripheral artery disease.

162 ast 90% of the attributable risk of coronary artery disease.

163 associated with the incidence of peripheral artery disease.

164 of FFRangio in patients with stable coronary artery disease.

165 ort of patients suspected of having coronary artery disease.

166 and low to intermediate-complexity coronary artery disease.

167 ) desensitization for patients with coronary artery disease.

168 lbuminuria) with the incidence of peripheral artery disease.

169 s (age: 63+/-9 years; 76% men) with coronary artery disease.

170 iplatelet agent, in patients with peripheral artery disease.

171 ND2 variant associated with CHD and coronary artery diseases found in a large Lebanese family with hi

172 ggested a link between migraine and cervical artery dissection (CEAD), any association between the 2

173 artery disease, migraine headache, cervical artery dissection, fibromuscular dysplasia, and hyperten

174 camera was held in a cradle over the carotid artery during iPhone measurements.

175 of carotid artery stenting (CAS) and carotid artery endarterectomy (CEA) for the prevention of stroke

176 rmal and PE STBEVs by primary human coronary artery endothelial cells (HCAEC) and the effects of free

177 t data support the notion that, in pulmonary artery endothelial cells (PAECs), expression of transcri

178 pregnancy-specific proliferation of uterine artery endothelial cells derived from pregnant (P-UAECs)

179 nd cigarette smoke extract on human coronary artery endothelial cells under oscillatory, normal lamin

180 derived head muscles (HMs) and hypobranchial artery endothelium, which we demonstrate are co-specifie

181 nd 230-microm spatial resolution at coronary artery evaluation in patients with atrial fibrillation (

182 ize a nanocarrier for siRNA for treatment of arteries ex vivo prior to implantation subsequently atte

183 riched in calcified regions of human carotid arteries, examined by immunohistochemistry.

184 pitulated in vitro by subjecting stem villus artery explants to hypoxia-reoxygenation, or inhibiting

185 moking control subjects we examined brachial artery flow-mediated dilation (FMD) and circulating micr

186 velopmental mechanisms underpinning coronary artery formation remain ill-defined.

187 nction were diminished in uterine (and tail) arteries from aged mice and post-menopausal women.

188 verlying atherosclerotic plaques in coronary arteries from patients with ischemic heart disease imply

189 itivity to PGF2alpha in the porcine coronary artery from males.

190 t a model in which DACH1 stimulates coronary artery growth by activating Cxcl12 expression and endoth

191 erior tibial and 13 (10.4%) posterior tibial arteries had >/=50% stenosis.

192 ameter stenosis >/=90% of noninfarct-related arteries (HR, 0.32; 95% CI, 0.18-0.62; P=0.001), but not

193 o distinguish true cervical internal carotid artery (ICA) occlusion from pseudo-occlusion (defined as

194 Moreover, the coating of the decellularized arteries improved biomechanical properties by increasing

195 re blood flow in an infarct-related coronary artery improves outcomes.

196 Stem villus arteries in human IUGR placentas displaying absent or re

197 rrectly identified culprit versus nonculprit arteries in patients with acute coronary syndrome (media

198 No patients with isolated vertebral artery injuries had positive transcranial Dopplers befor

199 oke among patients who sustained a vertebral artery injury with or without additional vessel injuries

200 valuated the association with common carotid artery intima-media thickness (cCIMT) using multivariabl

201 ults and evaluated associations with carotid artery intima-media thickness and plaque.

202 ation with nonobstructed epicardial coronary arteries is the prerequisite of normal myocardial perfus

203 priapism, chronic kidney disease, and large-artery ischemic stroke.

204 re generated in the left anterior descending artery (LAD), and 20 contrast material-enhanced volume s

205 ion measurements in the LAD, left circumflex artery (LCx), right coronary artery, and all three coron

206 n preclinical PAD models (unilateral femoral artery ligation and resection) were conducted to examine

207 mice were subjected to in vivo left coronary artery ligation for 30 minutes followed by 72 hours repe

208 ague-Dawley dams underwent bilateral uterine artery ligation or anesthesia (control) at e19.5.

209 /6 mice were subjected to permanent coronary artery ligation.

210 Left main coronary artery (LMCA) compression is increasingly recognized as

211 en performing unprotected left main coronary artery (LMCA) percutaneous coronary intervention (PCI),

212 nduction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlate

213 ld for using arterial grafts, and the radial artery may be the preferred second conduit.

214 interaction with the dilated main pulmonary artery (MPA).

215 ucing abundance at the surface of mesenteric artery myocytes.

216 or heart defects: transposition of the great arteries (n=7), coarctation of the aorta/hypoplastic aor

217 Permanent bilateral common carotid artery occlusion (BCCAO) was used as a model of vascular

218 s were subjected to a 2-hour middle cerebral artery occlusion (MCAO) and sacrificed at 24 hours of re

219 y the incidence and risk factors for retinal artery occlusion (RAO) in cardiac surgery.

220 cted to 60 min of reversible middle cerebral artery occlusion and evaluated for infarct volume, behav

221 lt ANX - A1 (-/-) mice subjected to coronary artery occlusion exhibited increased infarct size and LV

222 Retinal artery occlusion was identified by International Classif

223 A diagnosis of left ophthalmic artery occlusion was made.

224 oke and in mice subjected to middle cerebral artery occlusion, natural killer (NK) cells display rema

225 c cortical injury, transient middle cerebral artery occlusion, or neonatal hypoxic-ischemic brain inj

226 jury was induced by bilateral common carotid artery occlusion, whereas severe focal stroke injury was

227 smooth muscle from small resistance adipose arteries of non-diabetic and clinically diagnosed type 2

228 a fast intra-vascular sensor in the carotid artery of anaesthetized, mechanically ventilated pigs, w

229 eceiving PCI for an infarct-related coronary artery only.

230 ion group and in 121 patients in the infarct-artery-only group that did not receive complete revascul

231 Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions With A Novel Paclitaxel-Coat

232 We describe a pedicled internal mammary artery osteomyocutaneous chimeric flap (PIMOC) for salva

233 trinsic compression from a dilated pulmonary artery (PA) in patients with PAH and angina or angina-li

234 Remote monitoring of pulmonary artery (PA) pressures provides clinicians with actionabl

235 ry artery calcification (CARDIA) and carotid artery plaque burden (BioImage).

236 he primary outcome was noncalcified coronary artery plaque volume, as determined by coronary computed

237 e slows progression of noncalcified coronary artery plaque volume.

238 ed in clinical research for imaging coronary artery plaque, and ongoing clinical studies are testing

239 Diastolic pulmonary artery pressure and mean PAWP were measured to calculate

240 aims data from patients undergoing pulmonary artery pressure sensor implantation between June 1, 2014

241 Pulmonary hypertension (mean pulmonary artery pressure, >/=25 mm Hg) was present in 82 patients

242 regarded as moderate-severe (mean pulmonary artery pressure, >/=35 mm Hg) and 28 (34%) also had incr

243 D as per usual practice (diastolic pulmonary artery pressure-mean PAWP).

244 the pancreatic tail, diagnosed as a splenic artery pseudoaneurysm by CT.

245 ane and PGF2alpha are released from coronary artery PVAT from pigs.

246 Whether the use of the radial artery (RA) can improve clinical outcomes in coronary ar

247 ed during a 1-minute proximal right coronary artery (RCA) and left coronary artery balloon occlusion

248 of CT scans from the right and left femoral arteries, respectively.

249 -arginine acetate (l-NMMA) into both femoral arteries reversed the insulin-stimulated increase in mic

250 en and women from the observational Coronary Artery Risk Development in Young Adults study, aged 18 t

251 servational cohort studies (CARDIA [Coronary Artery Risk Development in Young Adults] and BioImage; n

252 In human artery-SCID chimeras, PD-1 blockade exacerbated vascular

253 Injured femoral arteries showed a 20% increase in neointimal hyperplasia

254 AIB and (3)H-taurine was reduced and uterine arteries showed increased relaxation.

255 nificantly greater number of small pulmonary artery side branches <300 mum per cm vessel (3.8 +/- 1.1

256 ry (BITA) over single left internal thoracic artery (SITA).

257 P values were adjusted for age, sex, carotid artery site, and family relations.

258 ing detected nanoparticles in human coronary artery-sized atheroma in vivo (P<0.05 versus reference s

259 lopathy characterized by excessive pulmonary artery smooth muscle cell (PASMC) proliferation, migrati

260 creased, the role of HIF-1alpha in pulmonary artery smooth muscle cells (PASMCs) remains controversia

261 he sheddases, ADAM10 and ADAM17 in pulmonary artery smooth muscle cells (PASMCs).

262 ximately 45-fold higher in isolated cerebral artery smooth muscle cells.

263 n patients with severe atherosclerotic renal artery stenosis scheduled for PTRA.

264 CAS against CEA for the treatment of carotid artery stenosis were selected.

265 for the prevention of stroke due to carotid artery stenosis.

266 e, and is independent of epicardial coronary artery stenosis.

267 calcium score (CACS) for predicting coronary artery stenosis.

268 tients with different severities of coronary artery stenosis.

269 ndex used to assess the severity of coronary-artery stenosis.

270 y disease due to de novo superficial femoral artery stenotic or occlusive lesions were randomized to

271 arding the relative effectiveness of carotid artery stenting (CAS) and carotid artery endarterectomy

272 Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1+/-1.6 yea

273 s study, patients with acute middle cerebral artery stroke with absence of cortical vein opacificatio

274 alyzing contraction of mesenteric resistance arteries supported the biological relevance of this mech

275 ter tracts, and involved the middle cerebral artery territory for 112 patients (73%).

276 ggrecan cleavage were more abundant in human arteries than in human veins.

277 30 mg group died during the study (pulmonary artery thrombosis and cardiorespiratory failure); neithe

278 them is upper limb ischemia caused by radial artery thrombosis.

279 so performed ferric chloride-induced carotid artery thrombosis.

280 ophilia that precedes development of carotid artery thrombus formation.

281 t occur without apparent epicardial coronary artery thrombus or stenosis.

282 ne diameter and volume from the lowest renal artery to the iliac bifurcation were the most sensitive

283 In old arteries treated with the FBA, saracatinib no longer inc

284 sures with exercise, and depressed pulmonary artery vasodilator reserve.

285 Brachiocephalic artery versus muscle CNR was 524 +/- 55 versus 518 +/- 1

286 Tibial artery vessels were classified as completely occluded, s

287 The artery wall is equipped with a water permeation barrier

288 ation of leukocyte-derived foam cells in the artery wall.

289 Following recovery, the brachial artery was cannulated and flushed with 10 000 U of hepar

290 ration and dynamic stress tests on pulmonary artery wave propagation and reservoir function.

291 ntially related to the use of mean pulmonary artery wedge pressure (PAWP).

292 Under local anesthesia, both uterine arteries were embolized.

293 Arteries were exposed to Ang II or Ang II plus BIM (for

294 Aortas and tail arteries were isolated from young (3-4 months) and old (

295 tact and pressurized rat superior cerebellar arteries were labelled for confocal immunofluorescence i

296 s to acetylcholine in pressurized mesenteric arteries were reduced in KW versus HW (P<0.01), whereas

297 Mice carrying inflamed human arteries were treated with tofacitinib or vehicle.

298 ial volume distensibility between peripheral arteries with different compliance.

299 METHODS AND In mouse carotid arteries with established intimal lesions tailored to re

300 US) of the left anterior descending coronary artery, within 8 weeks of HT.